U.S. Patent Protection Watch List Doesn’t Match PhRMA’s Wish List

U.S. Trade Representative places 10 countries on its “priority watch” list, including China and India, and 27 on its “watch list,” including Canada and Turkey; PhRMA requested that India and Turkey be put on the higher “priority foreign country” list and Canada be moved up to the priority watch list.

More from Legal & IP

More from Pink Sheet